Progentec Diagnostics
PrivateLast Round
Grant
Apr 9, 2026
Total Funding Raised
$6.48M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Progentec Diagnostics is a biotechnology company that develops proactive care solutions for systemic lupus erythematosus, multiple sclerosis, and other autoimmune diseases powered by proteomics and digital health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Progentec Diagnostics Comparables
Compare Progentec Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AMPEL BioSolutions | 87% | |
| Exagen Inc. | 80% | |
| GLX Analytix | 76% |
Progentec Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 9, 2026 | ||||
| Series A | Jan 8, 2020 | ||||
| Grant | Jul 25, 2019 | ||||
| Early Funding | Oct 31, 2018 | ||||
| Seed | Nov 27, 2017 |
Progentec Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| i2E | Seed, Early Funding |
| Plains Ventures | Series A |
| Mayo Clinic Ventures | Seed |
| Oklahoma Center for the Advancement of Science and Technology | Grant |
| OCA Ventures | Seed, Series A, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 41% MoM, reaching 2K.
- Jun 18, 2026
Monthly visitors increased 45% MoM to 1.4K.
Progentec Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Progentec Diagnostics's valuation, stock price, and market status.
Is Progentec Diagnostics a public or private company?
Progentec Diagnostics is a private company.
What is the current stock price of Progentec Diagnostics?
Progentec Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Progentec Diagnostics worth (valuation)?
Valuation information for Progentec Diagnostics is not publicly available.
Can I buy Progentec Diagnostics stock?
Progentec Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Progentec Diagnostics's last funding round?
Funding round information for Progentec Diagnostics is not publicly available.
Who are the main investors in Progentec Diagnostics?
Investor information for Progentec Diagnostics is not publicly disclosed.
Will Progentec Diagnostics IPO soon?
No public IPO plans have been announced for Progentec Diagnostics.
How can I track Progentec Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Progentec Diagnostics's secondary market activity and sign up for updates.